D1.4 Dissemination and Communication WP1 - Project coordination and technical management Campaign

D1.4 Dissemination and Communication Campaign WP1 Project Management, Dissemination, Exploitation, Communication This project is funded by the European Union Horizon Europe programme under grant agreement No 101046946 dŚŝƐƉƌŽũĞĐƚŚĂƐƌĞĐĞŝǀĞĚĨƵŶĚŝŶŐĨƌŽŵƚŚĞƵƌŽƉĞĂŶhŶŝŽŶƐ,ŽƌŝnjŽŶϮϬϮϬƌĞƐĞĂƌĐŚ and innovation programme under grant agreement No 952071 ϭϮͲWƌŽũĞĐƚYƵĂůŝƚLJ,ĂŶĚŬ WP1 - Project coordination and technical management Partner: PNO Authors: Carolina Salas, Antonio M. Ortiz, Jeanett Bolther Version: v.final Date: 31.08.2020 D1.4 Dissemination and Communication Campaign 2 PROJECT DETAILS AND DELIVERABLE INFORMATION PROJECT DETAILS Project Title On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs Project Acronym RESORB Call Identifier Horizon-EIC-2021-Pathfinder Open-01 Grant Agreement No. 1010469463 Duration 36 Project Start Date April 1st, 2022 Project Website www.resorb-project.eu DELIVERABLE INFORMATION Deliverable No 4 – D1.4 Deliverable Title Dissemination and Communication Campaign WP No 1 WP Leader UNIPI Contributing Partners / Nature R — Document, report Authors Giuseppe Barillaro Contributors Salvatore Surdo Reviewers Elisabetta Mazzotta, Jorge Morgado Delivery Date to EC M6 – September 30sh, 2022 DISSEMINATION LEVEL PU Public — fully open ( automatically posted online) v SEN Sensitive — limited under the conditions of the Grant Agreement EU classified EU classified — RESTREINT-UE/EU-RESTRICTED, CONFIDENTIEL-UE/EUCONFIDENTIAL, SECRET-UE/EU-SECRET under Decision 2015/444 D1.4 Dissemination and Communication Campaign 3 DOCUMENT HISTORY Version Date Author Description of Change 0.1 19.09.2022 Salvatore Surdo First Release 0.2 21.09.2022 Giuseppe Barillaro Internal Review 0.3 22.09.2022 Salvatore Surdo Second Release 0.4 28.09.2022 Salvatore Surdo Third Release 0.5 28.09.2022 Giuseppe Barillaro Internal Review 0.6 29.09.2022 Elisabetta Mazzotta Internal Review 1.0 30.09.2022 Salvatore Surdo Final Release D1.4 Dissemination and Communication Campaign 4 TABLE OF CONTENTS PROJECT DETAILS AND DELIVERABLE INFORMATION ........................... 2 GLOSSARY OF ACRONYMS ...................................................................... 5 1. EXECUTIVE SUMMARY ....................................................................... 7 2. COMMUNICATION MONITORING & CONTROL ................................. 7 3. COMMUNICATION ACTIONS .............................................................. 8 3.1 Twitter account. ............................................................................................. 8 3.2 Instagram account. ........................................................................................ 9 3.3 RESORB’s website ........................................................................................ 10 3.4 RESORB’s Gmail Account ............................................................................. 11 3.5 ResearchGate project page ......................................................................... 11 3.6 Communication with cancer patient associations ...................................... 12 3.7 Participation to national/international conferences .................................. 17 3.8 Press and Web News Release ..................................................................... 17 3.9 Participation to popular science events ...................................................... 18 3.10 Dissemination actions ............................................................................... 18 3.11 Collaborations with industries .................................................................. 18 4. BIBLIOGRAPHY/REFERENCES ........................................................... 19 D1.4 Dissemination and Communication Campaign 5 GLOSSARY OF ACRONYMS Acronym Extended Definition CD Communication Descriptor DCC Dissemination and Communication Campaign KVI Key Value Indicator UNIPI Università di Pisa D1.4 Dissemination and Communication Campaign 6 DISCLAIMER Views and opinions expressed in this Deliverable are those of the author only and do not necessarily reflect those of the European Union or European Commission. Neither the European Union nor the granting authority can be held responsible for them. D1.4 Dissemination and Communication Campaign 7 1. EXECUTIVE SUMMARY The aim of the deliverable D1.4 Dissemination and Communication Campaign (DCC) is to detail, monitor, and refine the implementation of the RESORB’s dissemination and communication plan [1]. In particular, the DCC identifies the tools we have exploited for sharing the RESORB vision and results with the targeted audiences. Moreover, this document identifies indicators of the effectiveness of our dissemination and communication campaigns. Such indicators will give us appropriate feedbacks to improve and/or adjust our communication actions. The implementation of the dissemination and communication campaigns is fully integrated into RESORB through the WP1 leaded by UNIPI. However, all the consortium members have been involved in the implementation and monitoring of the communication campaign. In this regard, the DCC can be considered as a living document, which we will be updated as soon as any action of the communication campaign is implemented and/or changed. All the RESORB partners will contribute to the updating of the DCC and will receive a copy of the amended DCC. 2. COMMUNICATION MONITORING & CONTROL A key point of the RESORB communication plan and strategy is generating an optimal flow of information between the RESORB “universe” and possible stakeholders at any moment in time. In this regard, it is essential to monitor and control the RESORB communication and to assess the information both flow and impact with respect to the dissemination, communication, and exploitation plan [1]. To this end, we identified the following communication descriptors (CDs) and key value indicators (KVIs): Communication Descriptors: • Author(s) and Contributor(s) of any action (source: RESORB partners) • Type of the action (source: RESORB partners); • Flow direction, namely, one-way exchange such as website and press release or twoway exchange such as exhibition, school visit (source: RESORB partners); • Main recipients (source: RESORB partners and analytical tools) • Date of the monitoring process (source: RESORB partners and analytical tools) • Place of the action, such as webpage, conference site (source: RESORB partners) • Content of the action (e.g., posts, press release, (source: RESORB partners) Key value indicators (i.e., size and/or impact of the action): • Number of visitors, downloads, documents, events on the RESORB project website (source: Google Search Console) • Number of followers, followings, reads, likes, and posts on the social media (source: Twitter-, ResearchGate-, LinkedIn-own statistics) • Number of stakeholders reached (source: RESORB partners), D1.4 Dissemination and Communication Campaign 8 • Number of external events with participation of the consortium partners (source: RESORB partners) • Number of participants in RESORB-own events (source: participants list) The outcomes of the monitoring process will be used to timely adjust the communication campaign and meet the goals of the communication plan, or to change and improve this latter. After making changes to the communication campaign, we will frequently monitor their effect through DCs and KVIs to determine the result of the modifications we made. This loop between 1) campaign, 2) monitor, and 3) control will allow reaching the largest number of target stakeholders, thus, extending the impact of RESORB beyond its lifecycle. 3. COMMUNICATION ACTIONS To implement the communication plan we used various tools/channels with their own specificity, which depends on several aspects including the targeted audience (i.e., general vs. specialized) or the way to communicate (i.e., one-way exchange vs. two-way exchange). 3.1 Twitter account. The Twitter account of RESORB, after it’s birth in May 2022, has started collecting followers and informing a broad audience (e.g., oncologists, citizens, and research labs) about the project aims, status, and achievements. D1.4 Dissemination and Communication Campaign 9 The RESORB Twitter account has the following DCs and KVIs: Author(s) Type Exchange direction Main recipient Date Place Content Size UNIPI Social media One-way 1. Civic society 2. Research community 19/ 09/2022 https://twitter.com/r esorb_project/ Posts Followings = 13 Followers = 12 Tweets&Replies= 5 We expect to further improve the KVIs of the project Twitter account in the following months when RESORB will lead to additional scientific results. 3.2 Instagram account. A RESORB’s Instagram account has been created on September 30th to inform the general public, but also scientific community and industrial professionals, about the project aims, status, and achievements. The RESORB Instagram account has the following DCs and KVIs: Author(s) Type Exchange direction Main recipient Date Place Content Size UNIPI Social media One-way 1. Civic society 2. Research community 19/ 09/2022 https://twitter.com/r esorb_project/ Posts Followings = 2 Followers = 2 Posts = 2 D1.4 Dissemination and Communication Campaign 16 AGREE AGREE AGREE DISAGREE DISAGREE AGREE Assessment of possible patient prejudices 1) Do you think that a fully bioresorbable and implantable sensor for monitoring in real-time the levels of a chemotherapeutic drug in the body might be advantageous for patients? YES VERY MUCH INDIFFERENT NOT AT ALL 2) Do you think that a fully bioresorbable and implantable sensor for monitoring in real-time the level of chemotherapeutic drugs in your body might make you feel better controlled than using traditional blood tests? YES VERY MUCH INDIFFERENT NOT AT ALL 3) Would be worried about receiving a bioresorbable implant? YES VERY MUCH INDIFFERENT NOT AT ALL 4) Do you think that such an implant would have some family, social, and economic consequences in your life? YES VERY MUCH INDIFFERENT NOT AT ALL 5) Do you think that chemotherapeutic drugs might have fewer side effects if the dosage is adjusted on the basis of the results coming from traditional blood test instead of a bioresorbable implant? YES VERY MUCH INDIFFERENT NOT AT ALL 6) Do you think that the bioresorbable implant would improve your life with respect to frequent hospital accesses? YES VERY MUCH INDIFFERENT NOT AT ALL D1.4 Dissemination and Communication Campaign 17 Please use this box for any comments or suggestions you whish to leave 3.7 Participation to national/international conferences National Conferences E. Mazzotta, T. Di Giulio, M. Corsi, S. Mariani, C. Malitesta, G. Barillaro, “A novel integration of molecularly imprinted polymers with nanoporous silicon for selective and sensitive optical detection of proteins”. XXIX Congresso della Divisione di Chimica Analitica della Società Chimica Italiana, 11-15 September 2022, Messina (Italy) International Conferences Corsi, M., Paghi, A., Mariani, S., Golinelli, G., Debrassi, A., Egri, G., Leo, G., Vandini, E., Vilella, A., Dähne, L., Giuliani, D., Barillaro, G., "Implantable and Bioresorbable Nanostructured Fluorescence Sensor for In Vivo Ph Monitoring", 2022 IEEE SENSORS, 30th October-2nd November 2022, Dallas (US). 3.8 Press and Web News Release RESORB “stories” are available at the UNIPI’s news pages (UnipiNews) and web release: https://www.unipi.it/index.php/component/k2/item/23833-un-sensore-bioriassorbibilesottopelle-puo-monitorare-i-segnali-del-corpo?Itemid=637; 23rd June 2022: “Un sensore bioriassorbibile sottopelle può monitorare i segnali del corpo” (English translation: A bioresorbable sensor implanted under the skin to monitor body signals); https://www.unipi.it/index.php/component/k2/item/22464-finanziato-resorb-il-primoprogetto-del-nuovo-programma-europeo-horizon-europe?Itemid=637; 19th November 2021: “Finanziato RESORB, il primo progetto del nuovo programma europeo Horizon Europe” (English translation: the new European Horizon Europe program has funded RESORB); https://www.repubblica.it/salute/2022/08/03/news/sensore_sottopelle_effetto_farmac i-360056468/; 3rd August 2022: “E con un sensore sottopelle sapremo se i farmaci fanno effetto” (English translation: A sensor under the skin will finally tell us whenever drugs are effective); https://medicoepaziente.it/2022/biosensori-impiantabili-la-nuova-frontiera-delladiagnostica/; 6th August 2022; “Biosensori impiantabili. La nuova frontiera della D1.4 Dissemination and Communication Campaign 18 diagnostica” (English translation: Implantable biosensors: the new frontier in diagnostics). 3.9 Participation to popular science events In order to raise awareness of the RESORB technology and gain social acceptance, we participated and/or planned to participate to the following popular science events: Bright Night, the EU Research Nigh 2022. Author(s) Title Location Date Audience Size G. Barillaro (UNIPI) Nanosensori biodegradabili: come potrebbe cambiare il monitoraggio di cibo, ambiente e salute (oral presentation) (English translation: Biodegradable nanosensors: how they would impact the monitoring of food, environment and health) Pisa 30.09.2022 * E. Mazzotta (UNISAL) Biomimetic receptors in bioresorbable sensors (poster presentation) Lecce 30.09.2022 * * to be updated on 30th September 2022 3.10 Dissemination actions RESORB has a new gold open-access publication: Corsi, M., Paghi, A., Mariani, S., Golinelli, G., Debrassi, A., Egri, G., Leo, G., Vandini, E., Vilella, A., Dähne, L., Giuliani, D., Barillaro, “Bioresorbable Nanostructured Chemical Sensor for Monitoring of pH Level In Vivo”, Adv. Sci. 2022, 2202062 (DOI: 10.1002/advs.202202062); https://onlinelibrary.wiley.com/doi/full/10.1002/advs.202202062 3.11 Collaborations with industries The RESORB technology has attracted the attention of “ab medica” a company that operates in the biomedical sector by offering appropriate, inclusive, sustainable patient care through the integration of clinical pathways with the best techniques and technologies available. Precisely, UNIPI and ab medica are discussing possible collaborations for the development of a wireless device that will read data recorded by the RESORB optical D1.4 Dissemination and Communication Campaign 19 sensors once implanted in the body and make them available to patient and doctors through a mobile app. 4. BIBLIOGRAPHY/REFERENCES 1. RESORB Dissemination, Communication, and Exploitation Plan 2. http://www.ecpc.org